Grant: Team Grant: Bringing Biology to Cancer Prevention - General Pool
University of Toronto
$0.00
Therapeutic interventions to prevent colon cancer caused by pks+ E.coli
FY 2025-26
Summary
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in Canada. Although significant efforts have been employed to understand the etiology of this cancer, the cause of this cancer is still unknown. Recent work has linked bacteria that reside in the gut to CRC, specifically, certain so-called "pathobionts", which are symbiotic members of the gut microbiota that can participate in disease under pathological conditions.
To understand the role of the pathobionts in CRC, we have assessed whether pathobionts cross-talk with other etiologic factors to promote CRC. Indeed, we recently showed that a specific E.coli bacteria that is found in up to 20% of healthy individuals can promote CRC when mice are fed a widely popular weight reducing diet that is low in carbohydrates and fibers. In addition, we show that this E.coli bacteria can promote CRC in mice harbouring mutations in a DNA repair gene (i.e. Mismatch Repair) that is commonly mutated in CRC patients. In short, our work is beginning to uncover the mechanisms by which pathobionts interact with specific etiologic factors to promote cancer.
Using these animal models, we will specifically assess what types of dietary fibres protect from CRC in mice. We will then determine whether specific fibres can reduce this E.coli bacteria in humans that are prone to develop CRC, including inflammatory bowel disease and Lynch syndrome patients. We will also test whether specifically targeting the respiration of this E.coli bacteria will reduce its levels in both mice and humans.
This work will inform new strategies related to dietary and lifestyle modifications, screening high-risk individuals, and personalizing the treatment modalities that could be employed in CRC prevention and therapy.
Department
Program
Team Grant: Bringing Biology to Cancer Prevention - General Pool
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560755
Name
Martin Alberto
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
The Terry Fox Research Institute (Vancouver, BC); Canadian Cancer Society - National Office (Toronto); Canadian Cancer Society - National Office (Toronto)
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Team Grant: Bringing Biology to Cancer Prevention
Projecttitle
Therapeutic interventions to prevent colon cancer caused by pks+ E.coli
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$0
Cihrequipment2
$0
Programname2
Team Grant: Bringing Biology to Cancer Prevention - General Pool
Keyworddelim
Carbohydrate; Colon Cancer; Diet; Fibre; Gut Microbes; Inflammatory Bowel Disease; Lynch Syndrome; Mismatch Repair; Pks+E.Coli
Abstract
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in Canada. Although significant efforts have been employed to understand the etiology of this cancer, the cause of this cancer is still unknown. Recent work has linked bacteria that reside in the gut to CRC, specifically, certain so-called "pathobionts", which are symbiotic members of the gut microbiota that can participate in disease under pathological conditions.
To understand the role of the pathobionts in CRC, we have assessed whether pathobionts cross-talk with other etiologic factors to promote CRC. Indeed, we recently showed that a specific E.coli bacteria that is found in up to 20% of healthy individuals can promote CRC when mice are fed a widely popular weight reducing diet that is low in carbohydrates and fibers. In addition, we show that this E.coli bacteria can promote CRC in mice harbouring mutations in a DNA repair gene (i.e. Mismatch Repair) that is commonly mutated in CRC patients. In short, our work is beginning to uncover the mechanisms by which pathobionts interact with specific etiologic factors to promote cancer.
Using these animal models, we will specifically assess what types of dietary fibres protect from CRC in mice. We will then determine whether specific fibres can reduce this E.coli bacteria in humans that are prone to develop CRC, including inflammatory bowel disease and Lynch syndrome patients. We will also test whether specifically targeting the respiration of this E.coli bacteria will reduce its levels in both mice and humans.
This work will inform new strategies related to dietary and lifestyle modifications, screening high-risk individuals, and personalizing the treatment modalities that could be employed in CRC prevention and therapy.
Competitiondate
202506
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Martin, Alberto; Armstrong, Heather; Croitoru, Kenneth
Approvedterm
5 ans 0 mois